does semaglutide cause bone loss Effects of Glucagon-Like Peptide-1 receptor agonists on health in people living with obesity GLP-1s may increase risk of

Brookshire: It is approved for type 2 diabetes

Rosen explained

In practice, enforcement varies dramatically

These medical spas were offering compounded versions of GLP-1s, marketing them as just as safe and effective as the versions approved by the Food and Drug Administration according to Yost

Women who had been drinking excessively or using illicit drugs for a decade or more said their addictive cravings diminished within weeks, or even days, after taking the injections

The market is growing due to the rising prevalence of diabetes, advancements in obesity treatments, and increasing demand for effective, long-acting therapies that offer improved patient outcomes